Last reviewed · How we verify
EV71 inactived vaccine(Human diploid cells) — Competitive Intelligence Brief
marketed
Biologic
Live · refreshed every 30 min
Target snapshot
EV71 inactived vaccine(Human diploid cells) (EV71 inactived vaccine(Human diploid cells)) — Sinovac Biotech Co., Ltd.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| EV71 inactived vaccine(Human diploid cells) TARGET | EV71 inactived vaccine(Human diploid cells) | Sinovac Biotech Co., Ltd | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- EV71 inactived vaccine(Human diploid cells) CI watch — RSS
- EV71 inactived vaccine(Human diploid cells) CI watch — Atom
- EV71 inactived vaccine(Human diploid cells) CI watch — JSON
- EV71 inactived vaccine(Human diploid cells) alone — RSS
Cite this brief
Drug Landscape (2026). EV71 inactived vaccine(Human diploid cells) — Competitive Intelligence Brief. https://druglandscape.com/ci/ev71-inactived-vaccine-human-diploid-cells. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab